Literature DB >> 1898997

The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion.

K Kwon1, S B Freedman, I Wilcox, K Allman, A Madden, G S Carter, P J Harris.   

Abstract

To investigate the incidence of early recurrent ST elevation after intravenous thrombolytic therapy for acute myocardial infarction, 12-lead electrocardiograms were continuously monitored for 571 +/- 326 minutes in 31 patients presenting within 4 hours of symptom onset. The study group comprised 9 women and 22 men (mean age +/- standard deviation 53 +/- 12 years), with ST elevation (anterior in 15, inferior in 16) on the initial electrocardiogram, who were given either tissue plasminogen activator (22 patients) or streptokinase (9 patients). Angiography was performed in 30 of 31 patients at 7 to 10 days. Early (less than 3 hours) resolution of ST elevation occurred in 19 patients (61%) at a median of 94 minutes (interquartile range 57 to 113) after thrombolysis, whereas 12 (39%) had no or late (greater than 6 hours) resolution. Eleven of the 19 with early resolution (58%) had either transient (5 patients) or sustained (6 patients) recurrences of ST elevation. Recurrent ST elevation was equal to or more than the initial peak elevation in 9 of 11 patients, and greater than 75% of initial peak in 2. A total of 25 episodes of recurrent ST elevation were observed in the 11 patients (19 transient and 6 sustained episodes), of which 8 (32%) were silent. The proportion of silent episodes was similar for transient (35%) and sustained (33%) recurrences. All patients with sustained recurrent ST elevation had at least 1 preceding transient recurrence. The median duration of transient recurrent ST elevation was 43 minutes (28 to 63).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898997     DOI: 10.1016/0002-9149(91)90430-s

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  The Open Artery Hypothesis: Past, Present, and Future.

Authors:  M Goel; J T Dodge; M Rizzo; C McLean; K A Ryan; W L Daley; C P Cannon; C M Gibson
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

Review 3.  The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

Authors:  M Vaturi; Y Birnbaum
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

4.  Coronary Artery Patency and Survival in Clinical Trials.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

5.  Early, Complete Infarct Vessel Patency: Arriving at a Gold Standard for Future Clinical Investigation in Myocardial Reperfusion.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

6.  Additional ST-segment elevation during thrombolytic therapy in patients with acute ST-elevation myocardial infarction: impact on myocardial salvage and final infarct size.

Authors:  Wolfgang Schreiber; Harald Kittler; Harald Herkner; Marianne Gwechenberger; Anton N Laggner; Michael M Hirschl
Journal:  Wien Klin Wochenschr       Date:  2003-02-28       Impact factor: 1.704

7.  ST variability during the first 4 hours of acute myocardial infarction predicts 1-year mortality.

Authors:  P Johanson; K Swedberg; M Dellborg
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-07       Impact factor: 1.468

8.  Usefulness of reperfusion ventricular arrhythmias in non-invasive prediction of early reperfusion and sustained coronary artery patency in acute myocardial infarction.

Authors:  J A Chiladakis; N Vlachos; N Patsouras; A Mazarakis; A S Manolis
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

Review 9.  Pharmacologic reperfusion therapy for acute myocardial infarction.

Authors:  Harry C Lowe; Briain D Mac Neill; Frans Van de Werf; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

10.  Assessment of Holter ST monitoring for risk stratification in patients with acute myocardial infarction treated by thrombolysis.

Authors:  R Stevenson; K Ranjadayalan; P Wilkinson; B Marchant; A D Timmis
Journal:  Br Heart J       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.